论文部分内容阅读
1976年CAPD问世以来,业已公认,它是CRF、ESRD较好的肾脏替代疗法之一。根据我国几个大城市的统计,CRF的发病率每年每百万人口约90人,而且还具有几个特点,其发病率以青壮年居多,在一定程度上随人口的增加而递增,有逐年累积的倾向。国外某些透析中心统计资料表明,接受透析治疗的CRF患者占人口1—3人/万,其中HD约占3/4。新近美国、日本资料提示能够接受肾移植的CRF的人数,也只占全部慢
Since the advent of the CAPD in 1976, it has been recognized that it is one of the better renal replacement therapies for CRF and ESRD. According to the statistics of several big cities in China, the incidence of CRF is about 90 people per million inhabitants per year, but also has several characteristics. The incidence of CRF is mostly young and middle-aged, and to some extent, it increases with the increase of population. Cumulative tendency. Some foreign dialysis center statistics show that the dialysis CRF patients accounted for 1 to 3 people / million, of which HD accounted for about 3/4. Recently the United States, Japan, the number of people prompted CRF can accept renal transplantation, only the slow